Latest News about Abbvie Inc
Recent news which mentions Abbvie Inc
From CNBC.com News
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
Ad spending on women's sports more than doubled last year
March 11, 2025
From CNBC.com News
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
February 04, 2025
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
October 16, 2024
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
From CNBC.com News
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
February 20, 2024
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
February 14, 2024
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
February 08, 2024
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
From CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
From CNBC.com News
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
From CNBC.com News
From CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
October 13, 2023
From CNBC.com News
From CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
From CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Free News Feed
Get our RSS Feed!
© Copyright 2008 StreetInsider.com
Custom Website Design by Active Media Architects
Custom Website Design by Active Media Architects
